Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Camilleri

Showing results (1-10 of 444) with videos related to

Pageof 45
Sort By:
Gastroenterology|February 7, 1998
What's in a name? Roll on Rome IIM Camilleri
Neurogastroenterology and Motility|January 25, 2007
Is there an experimental basis for the development of ischaemic colitis as a result of 5-HT3 antagonist treatment?M Camilleri
Neurogastroenterology and Motility|March 25, 2005
Alvimopan, a selective peripherally acting mu-opioid antagonistM Camilleri
Digestive Diseases and Sciences|May 1, 1993
Study of human gastroduodenojejunal motility. Applied physiology in clinical practiceM Camilleri
Alimentary Pharmacology & Therapeutics|September 30, 2009
Review article: new receptor targets for medical therapy in irritable bowel syndromeM Camilleri
Gastroenterology|March 29, 2000
Ten secrets for development of drugs for functional gastrointestinal diseasesM Camilleri
Gut|June 22, 2002
Testing the sensitivity hypothesis in practice: tools and methods, assumptions and pitfallsM Camilleri
Clinical Pharmacology and Therapeutics|November 11, 2011
Pharmacology of the new treatments for lower gastrointestinal motility disorders and irritable bowel syndromeM Camilleri
Mayo Clinic Proceedings|December 1, 1988
Organic basis for symptoms in functional gastrointestinal disease?M Camilleri
Neurogastroenterology and Motility|May 27, 2005
Mechanisms in IBS: something old, something new, something borrowedM Camilleri
Pageof 45

Showing results (1-10 of 444) with videos related to

Sort By:
Pageof 45
Gastroenterology|February 7, 1998
What's in a name? Roll on Rome IIM Camilleri
Neurogastroenterology and Motility|January 25, 2007
Is there an experimental basis for the development of ischaemic colitis as a result of 5-HT3 antagonist treatment?M Camilleri
Neurogastroenterology and Motility|March 25, 2005
Alvimopan, a selective peripherally acting mu-opioid antagonistM Camilleri
Digestive Diseases and Sciences|May 1, 1993
Study of human gastroduodenojejunal motility. Applied physiology in clinical practiceM Camilleri
Alimentary Pharmacology & Therapeutics|September 30, 2009
Review article: new receptor targets for medical therapy in irritable bowel syndromeM Camilleri
Gastroenterology|March 29, 2000
Ten secrets for development of drugs for functional gastrointestinal diseasesM Camilleri
Gut|June 22, 2002
Testing the sensitivity hypothesis in practice: tools and methods, assumptions and pitfallsM Camilleri
Clinical Pharmacology and Therapeutics|November 11, 2011
Pharmacology of the new treatments for lower gastrointestinal motility disorders and irritable bowel syndromeM Camilleri
Mayo Clinic Proceedings|December 1, 1988
Organic basis for symptoms in functional gastrointestinal disease?M Camilleri
Neurogastroenterology and Motility|May 27, 2005
Mechanisms in IBS: something old, something new, something borrowedM Camilleri
Pageof 45